Decera Clinical Education Neuroscience Podcast · Decera Clinical Education

Therapy Trends & Tipping Points in MS: A Case-Based Look at High-Risk Disease and Emerging Treatments

·17 min·1 clip

Intranasal anti-CD3 monoclonal antibody reduced fatigue in 70% of secondary progressive MS patients in a limited study.

Dr. Patricia Coyle discusses emerging treatments for multiple sclerosis, focusing on BTK inhibitors, CNS repair strategies, and case-based approaches to high-risk disease. She explores future directions including stem cell therapies, AI-driven disease classification, and novel drug delivery methods like intranasal antibodies.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Decera Clinical Education Neuroscience Podcast